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Copyright © 200? JCBN 200? This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. During endoscopic examinations we collected fluid in the stomach
that included reflux fluid from the duodenum, and assessed the
effect of quantitatively determined bile acids on glandular atrophy
and intestinal metaplasia using biopsy specimens. A total of 294
outpatients were enrolled in this study. Total bile acid concentra-
tion was measured by an enzyme immunoassay. Glandular atrophy
and intestinal metaplasia scores were graded according to the
Updated Sydney System. An effect of refluxed bile acids on
atrophy and intestinal metaplasia was shown in the high-
concentration reflux group in comparison with the control group.
However, when the odds ratios (ORs) were calculated according
to whether Helicobacter pylori (H. pylori) infection was present,
no significant associations were shown between reflux bile acids
and atrophy in either the H. pylori-positive cases or -negative
cases. The same was true for intestinal metaplasia in the H. pylori-
positive cases, whereas intestinal metaplasia was more pro-
nounced in the high-concentration reflux group in the H. pylori-
negative cases (OR 2.4, 95%CI 1.1–5.6). We could not clarify the
effect of the reflux of bile acids into the stomach in the progres-
sion of atrophy. High-concentration bile acids had an effect on the
progression of intestinal metaplasia in the H. pylori-negative cases.
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Introduction It is known that the superficial gastritis that occurs in associa-
tion with Helicobacter pylori (H. pylori) infection progresses
to atrophic gastritis, and that over time intestinal metaplasia
occurs,(1) and stomach cancer develops. Excessive salt intake,
insufficient intake of fresh fruit and vegetables, etc., as well as H.
pylori has been demonstrated to play an important role as factors
in the progression of atrophic gastritis,(2) and there is also a report
in relation to a synergistic effect of refluxed bile acids and H.
pylori.(3) On the other hand, the incidence of the cancer in the
remnant stomach after Billroth II reconstruction is higher than
after Billroth I reconstruction.(4) An effect of reflux of bile-
containing duodenal fluid has been pointed out as the incidence of
the cancer,(5) and it has been confirmed in animal experiments.(6)
However, there have been few studies on the effect of bile acids
that reflux into the stomach in association with duodenogastric
reflux (DGR) on atrophy and intestinal metaplasia in cases with no
history of gastric resection.(7,8) We therefore collected intragastric
juice containing refluxed bile acids from the duodenum in subjects
undergoing an endoscopic examination and investigated whether
there was an association between refluxed bile acids and either
atrophy or intestinal metaplasia in biopsy tissue. We also observed
the relationship between H. pylori infection and atrophic gastritis
based on serum pepsinogen values.
Materials and Methods
Materials. A total of 294 outpatients (mean age 58.7 years,
range 20–86 years, sex ratio 182:112) who were examined at the
Tama-Nagayama University Hospital of Nippon Medical School
were enrolled in this study. The survey of the gastric mucosa that
included collection of gastric juice and diagnosis of H. pylori
infection was being an adult 20 years of age or over. An upper
gastroduodenal endoscopic examination was performed in every
subject. Subjects who had a history of gastric surgery or preg-
nancy, who fulfilled any of the exclusion criteria below, or who
were judged to be unsuitable because it might be impossible to
perform an endoscopic examination were excluded from this
study. This study was approved by the ethics committee of Tama-
Nagayama University Hospital of Nippon Medical School, and
written informed consent was obtained from all subjects.
Gastric juice collection. The endoscopic examinations were
performed in the early morning after an overnight fast, without
ingesting any food or liquids or taking any medication. When the
examinations were performed, no gastric mucolytic and mucus
removing agents, foaming mucus removing agents, or gastro-
intestinal motility inhibitors were used, and the subjects were
asked to expectorate all of the local anesthetic that was used for
pharyngeal anesthesia. In order to prevent postural reflux of fluid
in the duodenum into the stomach, the subjects were maintained in
the seated position until just before the start of the examination.
Whenever reflux of duodenal fluid into the stomach through the
pyloric ring was detected during the examination of the stomach,
the subject was excluded as a subject in order to eliminate effects
associated with posture during the examination, i.e., the left lateral
position.
As much of the gastric contents that had collected in the fornix
or greater curvature side of the body of the stomach as possible
was aspirated immediately before the endoscopic examination.
The gastric juice was aspirated via the forceps channel in the
endoscope and captured in a recovery vessel. Whenever a bleeding
lesion was observed or whenever the mucosa was injured during
aspiration of the gastric juice and bleeding was observed, the
subject was excluded as a subject because of the possibility of
measuring bile acids in the blood that had commingled with the
gastric juice. After the collection of gastric contents, gastric
mucolytic and mucus removing agents, foaming mucus removing
agents were used.
Measurement of the bile acid concentration. The fluid that
had been collected was immediately frozen and stored (−20°C),
and the total bile acid concentration was measured by an enzy-
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matic assay (Daiichi Pure Chem. Co., Ltd., Tokyo, Japan)(9) by the
outsource (SRL, Inc., Tachikawa, Japan).
Serum pepsinogen values. Pepsinogen (PG) I and II values
were measured in serum collected before the endoscopic examina-
tion, and the I/II ratio was calculated. The PG I and II measure-
ments were made by means of a chemiluminescent enzyme
immunoassay (CLEIA). When the PG I value was ≤70 ng/ml and
the I/II ratio was ≤3.0, the specimen was recorded as PG-positive,
otherwise it was recorded as PG-negative.(10)
Diagnosis of atrophy, intestinal metaplasia, and H. pylori
infection. Biopsy specimens for histological diagnosis, in-
cluding of H. pylori infection, were collected from the greater
curvature of the distal antrum (#1), the greater curvature of the
proximal body (#2), and the lesser curvature of the distal body (#3)
in accordance with the triple-site gastric biopsy method.(11,12)
Hematoxylin-eosin staining was performed to make the histo-
logical diagnosis. Giemsa stain and H. pylori-specific antibody
immune stain (Dako, Clostrup, Denmark) in selected cases were
used to diagnose H. pylori infection.
Glandular atrophy, intestinal metaplasia, and H. pylori scores
were graded according to the Updated Sydney System into the
following four grades as follows: 0, none; 1, mild; 2, moderate;
and 3, severe.(3) When the grade of atrophy, intestinal metaplasia,
or H. pylori infection was 0, the subject was classified as negative
that parameter, and when the score for atrophy, intestinal meta-
plasia, or H. pylori infection was 1, 2, or 3, the subject was
classified as positive for that parameter. The histological diagnosis
in the biopsy specimens was made by one pathologist (Yamada
N.) using the same criteria.
Statistical analysis. The mean bile acid concentrations were
expressed as mean ± standard error (SE).
The subjects whose total bile acid concentration was below the
sensitivity of detection by the assay (3 nmol/ml) were assigned to
the control group, and the subjects whose concentrations were
above the sensitivity of detection were divided into 3 equal groups
starting with the subjects who had the lowest concentrations:
Group A (0–33%), Group B (34–66%), and Group C (67–100%).
The odds ratios (ORs) and 95% confidence intervals (CIs) of
groups A, B, and C, when the odds for the occurrence of atrophy,
occurrence of intestinal metaplasia, and H. pylori infection in the
control group were set equal to 1, were each calculated. Similarly,
the OR and 95%CI of the H. pylori-positive cases when the PG-
positive odds of the H-pylori-negative cases was set equal to 1,
and the intestinal metaplasia-positive OR and 95%CI when the
occurrence of atrophy odds of the intestinal-metaplasia-negative
cases was set equal to 1, were calculated. The 95%CIs of the ORs
were calculated by the Woolf’s method.(13)
Results
The 294 subjects consisted of 6 patients with early stomach
cancer, 2 patients with gastric mucosa-associated lymphoid tissue
(MALT) lymphoma, 104 patients with peptic ulcer disease, 21
patients gastric polyp, 78 patients gastritis (erosive gastritis,
gastric erosion, superficial gastritis, and hemorrhagic gastritis), 4
patients with reflux esophagitis, and 79 normal group subjects
who had no evidence of any local lesions (including atrophic
gastritis) in the upper gastrointestinal tract (Table 1).
Bile acid reflux was observed in 189 (64.3%) of the 294 sub-
jects of the study. No significant differences in incidence of bile
acid reflux or in bile acid concentration were found among the 3
groups containing the largest numbers of subjects: the peptic ulcer
disease group, the normal group, and the gastritis group (Table 1).
The rate of H. pylori infection among the subjects was 27.2%.
No associations were found between the presence or absence of
H. pylori infection and the refluxed bile acid concentration in the
comparison between the control group and any of Group A, Group
B, or Group C (Table 2).
PG-positive subjects were more common among the H. pylori-
positive subjects than among the H. pylori-negative subjects
(OR 7.9, 95%CI 4.3–14.7) (Table 3).
According to the pathological diagnosis by the triple-site biopsy
method, there was a stronger tendency for intestinal metaplasia to
be seen among the subjects whose biopsies showed atrophy in
Table 1. Endoscopic diagnosis, concentration of bile acids in gastric juice, incidence of bile acid reflux into the
stomach
Kruskal-Wallis’s test: *,**,***p = 0.1921. Fisher’s exact test: ****,*****p = 0.08, ****,******p = 0.26, *****,******p =
0.62. No significant differences in incidence of bile acid reflux or in bile acid concentration were found among the
peptic ulcer disease group, the normal group, and the gastritis group.
Endoscopic diagnosis n Bile acid concentration (mean ± SD) Incidence of reflux
Gastric cancer 6
Gastric MALToma 2
Peptic ulcer disease 104 186.8 ± 320.3 nmol/ml* 73.1%****
Gastric polyp 21
Gastritis 78 347.0 ± 1072.4 nmol/ml** 60.3%*****
Reflux esophagitis 4
Normal group 79 323.7 ± 989.5 nmol/ml*** 64.6%******
Total 294 250.0 ± 780.7 nmol/ml 64.3%
Table 2. Relation between H. pylori infection and the refluxed bile acid cocentration
No associations were found between the presence or absence of H. pylori infection and the refluxed bile acid
concentration in the comparison between the control group and any of Group A, Group B, or Group C.
Group n
H. pylori infection
Odds OR 95%CI
Negative Positive
Control 105 74 31 0.419 1.0
A 61 46 15 0.326 0.8 0.4–1.6
B 65 49 16 0.327 0.8 0.4–1.6
C 63 45 18 0.400 1.0 0.5–1.9 J. Clin. Biochem. Nutr. | May 2012 | vol. 50 | no. 3 | 219
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specimens #1 and #3 than among the subjects whose biopsies did
not (Table 4).
Based on the results of the total bile acid concentrations
measurements, there were 105 subjects in the control group, 61 in
Group A (3–29 nmol/ml), 65 in Group B (30–199 nmol/ml), and
63 in Group C (200 nmol/ml and over).
Atrophy and intestinal metaplasia in specimen #1 were marked
in Group C in comparison with the control group (atrophy: OR
5.1, 95%CI 1.2–21.7; intestinal metaplasia: OR 2.3, 95%CI 1.1–
4.6), but no significant differences were found between either
Group A or Group B and the control group. When the results were
examined according to whether H. pylori infection was present, no
significant differences in atrophy from the control group were
found in either the H. pylori-positive group or the H. pylori-
negative group (Table 5). The same was true in regard to intestinal
metaplasia in the H. pylori-positive group (Table 5). In the H.
pylori-negative group, however, intestinal metaplasia was more
marked in Group C than in the control group (OR 2.4, 95%CI
1.1–5.6) (Table 5).
Table 3. Relation between the results of the pepsinogen (PG) test and H. pylori infection
PG-positive subjects were more common among the H. pylori-positive subjects than among the H. pylori-negative subjects.
H. pylori infection n
PG test
Odds OR 95%CI
Negative Positive
Negative 214 192 22 0.115 1.0
Positive 80 42 38 0.905 7.9 4.3–14.7
Table 4. Relation between glandular atrophy and intestinal metaplasia according to the results of histological examination of biopsy specimens
obtained by the triple-site biopsy method
According to the pathological diagnosis by the triple-site biopsy method, there was a stronger tendency for intestinal metaplasia to be seen among
the subjects whose biopsies showed atrophy in specimens #1 and #3 than among the subjects whose biopsies did not.
Specimen number Intestinal 
metaplasia n
Glandular atrophy
Odds OR 95%CI
Negative Positive
#1 greater curvature of the distal antrum
Negative 115 109 6 0.055 1.0
Positive 18 5 13 2.600 47.3 12.6–176.6
#2 greater curvature of the proximal body
Negative 186 178 8 0.045 1.0
Positive 1 1 0
#3 lesser curvature of the distal body
Negative 113 96 17 0.177 1.0
Positive 48 5 43 8.600 48.6 16.8–140.2
Table 5. Glandular atrophy (A) and intestinal metaplasia (B) according to the bile acid concentration and according to whether H. pylori infection
was present or absent
Atrophy and intestinal metaplasia in specimen #1 were marked in Group C in comparison with the control group, but no significant differences
were found between either Group A or Group B and the control group. When the results were examined according to whether H. pylori infection
was present, no significant differences in atrophy from the control group were found in either the H. pylori-positive group or the H. pylori-negative
group. The same was true in regard to intestinal metaplasia in the H. pylori-positive group. In the H. pylori-negative group, however, intestinal
metaplasia was more marked in Group C than in the control group.
(A) Group n
Glandular atrophy
Odds OR 95%CI
Negative Positive
Total
Control 105 46 3 0.065 1.0
A 61 26 3 0.115 1.8 0.3–9.4
B 65 21 6 0.286 4.4 0.99–19.2
C 63 21 7 0.333 5.1 1.2–21.7
H. pylori (+)
Control 26 8 1 0.125 1.0
C 19 4 5 1.250 10.0 0.9–117.0
H. pylori (−)
Control 79 38 2 0.053 1.0
C 44 17 2 0.118 2.2 0.3–17.2
(B) Group n
Intestinal metaplasia
Odds OR 95%CI
Negative Positive
Total
Control 105 84 21 0.250 1.0
A 61 52 9 0.173 0.7 0.3–1.6
B 65 49 16 0.327 1.3 0.6–2.7
C 63 40 23 0.575 2.3 1.1–4.6
H. pylori (+)
Control 26 20 6 0.300 1.0
C 19 12 7 0.583 1.9 0.5–7.2
H. pylori (−)
Control 79 64 15 0.234 1.0
C 44 28 16 0.571 2.4 1.1–5.6doi: 10.3164/jcbn.11-90
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Discussion
The main cause of chronic atrophic gastritis, which is prevalent
among Japanese, has been found to be related to H. pylori.(14)
Intestinal metaplasia, which is characterized by the occurrence
of goblet cells, absorptive epithelial cells, and, at times, Paneth
cells is another change that is frequently seen in the gastric mucosa
of Japanese.(3) Intestinal metaplasia is known to be a change that
occurs secondary to chronic atrophic gastritis,(15) but the factors
that contribute to intestinal metaplasia and its significance are
unclear. In 1987 the authors reported an association between
refluxed bile acids in the stomach and the endoscopic form of the
pylorus.(16) In the present study we investigated whether refluxed
bile acids in the stomach affect the progression of atrophy and
intestinal metaplasia.
Old studies found higher refluxed bile acid concentrations in
gastric ulcer groups than in control groups,(17,18) and there is a
report that the higher concentrations are due to a decrease in
gastric secretion not due to increased DGR.(19) On the other hand,
no differences were found in secondary bile acid composition,
including deoxycholic acid, between stomach cancer patients
and a control group.(20) Even in our own study, no differences in
the incidence of reflux or in its concentration were seen among the
peptic ulcer disease group, gastritis group, and normal group. We
therefore carried out our study of reflux bile acids regardless of
the disease. That was because atrophic gastritis and intestinal
metaplasia are often seen in Japanese, and the purpose of our study
was to elucidate the relation between the gastric mucosa and bile
acids.
The gastric juice collection during the endoscopic examination
was performed in the morning after an overnight fast. However,
since the examination time varied with the subject and there were
differences in the degree of the patients’ anxiety the examination,
it is almost impossible to a condition the same between subjects.
Moreover, there are investigators who question the reproducibility
of the refluxed bile acids,(7) and because the present study was a
cross-sectional study, we did not take reproducibility into account.
Bile acids have been experimentally confirmed to inhibit the
growth of H. pylori,(21) and H. pylori are known to be eradicated in
patients who have undergone gastric surgery.(22) In our own study,
which was conducted on subjects who had not undergone gastric
resection, no decrease in H. pylori infection rate was shown even
in Group C, which had a high reflux bile acid concentration. A
study of patients with dyspepsia or gastritis reported no significant
difference in H. pylori infection rate between a group with bile
acid reflux and a group without bile acid reflux (36.9% and 54.5%,
respectively),(23) and thus the results were similar to our own. In
contrast to the postoperative stomach, the refluxed bile acids are
drained into the duodenum by pyloric function in unresected
patients. We think they have no effect in decreasing the H. pylori
infection rate.
It is an unquestioned fact that long-term H. pylori infection
greatly contributes to the progression and expansion of atrophic
gastritis.(24) The PG method measures the serum PG concentration,
and is used to pick up persons with atrophic gastritis, which is a
high-risk group for stomach cancer. It is widely used for gastric
cancer screening in Japan as objective and correct serodiagnostic
method for atrophic gastritis.(25) The results of our study also
showed significantly more PG-positive subjects in the H. pylori-
positive group (OR: 7.9, 95%CI 4.3–14.7), thereby corroborating
the results indicating that H. pylori infection has an effect on
atrophy.
A review of the relationship between atrophic gastritis and
intestinal metaplasia in the greater curvature of the distal antrum
(biopsy specimen #1) and lesser curvature of the distal body
(biopsy specimen #3) showed that the atrophy-positive odds
were higher in the intestinal metaplasia-positive group than in the
intestinal metaplasia-negative group. Atrophic gastritis spreads
from the pylorus to the body of the stomach with increasing age,(26)
and intestinal metaplasia develops over the course of 10 or so
years after the atrophic changes appear.(27) Intestinal metaplasia
starts in the pyloric gland region, and it mainly ascends the lesser
curvature gradually and in a linear fashion to the fundic gland
mucosa， and in the fundic gland mucosa it spreads from the lesser
curvature to the greater curvature.(28) It is possible to understand
the results in biopsy specimens #1 and #3 in our study on the basis
of these facts as well.
Based on the fact that many differentiated stomach cancers
develop in gastric mucosa that exhibit intestinal metaplasia,
Matsukura et al.(20) reported that intestinal metaplasia in the gastric
mucosa is a precancerous condition. In a study by Uemura et al.(30)
there was a high rate of development of stomach cancer in subjects
with H. pylori infection, especially in patients with severe atrophic
gastritis and severe intestinal metaplasia. On the other hand,
although most differentiated stomach cancers are associated with
intestinal metaplasia around them, there are objections to the view
that regards intestinal metaplasia as a precancerous condition.(31)
Tatematsu et al.(32) have stated that the intestinal metaplasia that is
seen in the process of progression of atrophic gastritis is an
abnormality of differentiation that occurs at the stem cell level,
that H. pylori infection promotes this process, that cancer is a
gene abnormality that occurs in precursor cells that have differen-
tiated from stem cell，and that intestinal metaplasia and carcino-
genesis are separate phenomena that occur in parallel. Moreover,
because H. pylori infection is not observed in mucosa affected
by intestinal metaplasia, there is also the view that intestinal
metaplasia in the gastric mucosa is an aggressive immunological
adaptation phenomenon by the body to H. pylori infection.(33)
As the antrum is readily affected by DGR, atrophy and intestinal
metaplasia is often recognized with endoscopic examination and
histological diagnosis. For this reason, we used specimen #1 (the
distal antrum) to investigate the effect of bile acids on atrophy and
intestinal metaplasia. It has been shown that bile acids may affect
atrophy of the gastric mucosa, but when examined according to
whether H. pylori infection was present or not, no effect of bile
acids was observed in either a positive group or a negative group.
It was impossible to demonstrate synergism between bile acids
and H. pylori(3) in the H. pylori-positive subjects by our results.
Because of the powerful effect of H. pylori infection as a risk
factor for atrophy, the possibility that the effect of bile acids is
concealed cannot be ruled out. An effect of bile acids on intestinal
metaplasia has also been shown, but when examined according to
whether H. pylori was present, no effect of bile acids on intestinal
metaplasia was seen in the H. pylori-positive group. Nakamura
et al. have stated the possibility of the progression of intestinal
metaplasia is affected by DGR.(8) The fact that there were few
H. pylori-positive subjects in 294 subjects appears to be one of the
factors involved in why no association between reflux bile acids
and intestinal metaplasia was found in the H. pylori-positive
group. The H. pylori infection rate among persons who underwent
an upper gastrointestinal endoscopic examination in our depart-
ment was approximately 53% (data not shown). Many young
subjects, who have a low rate of H. pylori infection, were included
in this study among the subjects who received a stomach screening
examination at another institution and received a second endo-
scopic examination based on the results. On the other hand, a
high concentration of bile acids was found to affect intestinal
metaplasia in the H. pylori-negative group. Tatematsu et al. have
stated that intestinal metaplasia is promoted by H. pylori,(32) but
it is also induced by antigen stimuli other than H. pylori.(33) Our
results that intestinal metaplasia occurs in the high bile acid
concentration group of H. pylori-negative subjects support this.
An effect of reflux bile acids on intestinal metaplasia and
carcinogenesis has been shown in animal experiments.(34) Another
report states pancreaticoduodenal secretions is implicated in
gastric carcinogenesis in the rat.(35) A study that includes bile J. Clin. Biochem. Nutr. | May 2012 | vol. 50 | no. 3 | 221
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acids and pancreaticoduodenal secretions seems to be needed.
In conclusion, H. pylori infection plays a major role in the
progression of atrophy, but it was impossible to demonstrate an
effect of bile acid reflux into the stomach. High concentrations
of bile acids were shown to have an effect on the progression of
intestinal metaplasia in H. pylori-negative subjects, but there was
no clear effect of bile acids in positive subjects. Based on our
experience in this study, we plan to conduct a study on a large
number of subjects in a multi-center cooperative study in Japan.
Abbreviations
CI confidence interval
CLEIA chemiluminescent enzyme immunoassay
DGR duodenogastric reflux
H. pylori Helicobacter pylori
MALT mucosa-associated lymphoid tissue
OR odds ratio
PG pepsinogen
SE standard error
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